Inventiva S.A. (IVA)
NASDAQ: IVA · Real-Time Price · USD
3.160
-0.160 (-4.82%)
At close: Oct 9, 2026, 4:00 PM EDT
3.100
-0.060 (-1.90%)
After-hours: Oct 9, 2026, 7:25 PM EDT
Inventiva Employees
Inventiva had 87 employees as of June 30, 2026. The number of employees increased by 10 or 12.99% since the number was reported on December 31, 2025.
Employees
87
Change
10
Growth
12.99%
Revenue / Employee
$32,252
Profits / Employee
-$3,253,046
Market Cap
756.65M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 87 | 10 | 12.99% | 87 | 0 |
| Dec 31, 2025 | 77 | -41 | -34.75% | 69 | 8 |
| Dec 31, 2024 | 118 | -5 | -4.07% | 114 | 4 |
| Dec 31, 2023 | 123 | 10 | 8.85% | 120 | 3 |
| Dec 31, 2022 | 113 | 8 | 7.62% | 109 | 4 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Gyre Therapeutics | 625 |
| 4D Molecular Therapeutics | 196 |
| Solid Biosciences | 121 |
| Verastem | 102 |
| Annexon | 92 |
| Lexicon Pharmaceuticals | 81 |
| Apnimed | 81 |
| Candel Therapeutics | 55 |
IVA News
- 1 day ago - 3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Ahead - MarketBeat
- 4 days ago - Inventiva to Present Scientific Abstracts at AASLD The Liver Meeting® 2026 - GlobeNewsWire
- 7 days ago - Inventiva Eyes Q4 2026 Phase III MASH Data as Lanifibranor Nears Key Test - MarketBeat
- 9 days ago - Inventiva price target raised to $18 from $13 at Truist - TheFly
- 11 days ago - Inventiva Transcript: Stifel 2026 Virtual Cardiometabolic Forum - Transcripts
- 11 days ago - Inventiva (IVA): H1 Results Put Cash Runway and NATiV3 at the Center of the Story - AlphaStreet
- 12 days ago - Inventiva (IVA) Q2 2026 Earnings Call Transcript - The Motley Fool
- 12 days ago - Inventiva price target raised to $21 from $20 at Canaccord - TheFly